Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia

Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2018.05.025
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Do We Need a Different Transfusion Strategy in Patients With Chronic Kidney Disease Undergoing CABG?

Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular MedicineAnesthesiologyPain MedicineCardiology
2017English

Thrombocytopenia in Liver Disease

Canadian Journal of Gastroenterology
2000English

Trimethadione Metabolism in Patients With Normal Liver and in Patients With Chronic Liver Disease.

Journal of Pharmacobio-Dynamics
1987English

The Effects of Various Platelet Transfusion Thresholds in Preterm Infants With Severe Thrombocytopenia

Acta Paediatrica, International Journal of Paediatrics
MedicineChild HealthPediatricsPerinatology
2019English

Evolution of Platelet Function in Adult Patients With Chronic Immune Thrombocytopenia on Romiplostim Treatment

British Journal of Haematology
Hematology
2019English

Factors Associated With the Need for Intraoperative Packed Red Cells Transfusion in Pediatric Liver Transplant Patients

Bali Journal of Anesthesiology
2019English

Relative Potency of the Thrombopoietin Receptor Agonists Eltrombopag, Avatrombopag and Romiplostim in a Patient With Chronic Immune Thrombocytopenia

British Journal of Haematology
Hematology
2018English

Serum Selenium Level in Patients With Chronic Liver Disease

Sohag Medical Journal
2017English

Deferasirox Reduces Oxidative Stress in Patients With Transfusion Dependency

Journal of Clinical Medicine Research
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy